The pivotal strength of our study is that it is the first prospective investigation of the potential value of serial IP-10 and TRAIL measurements as indicators of inflammatory status and viral clearance, respectively, in COVID-19 patients. The gene discussed is CXCL10; the disease is COVID-19.